Microcapsules and microparticles are widely used to carry, deliver and protect pharmaceutical agents in drugs, fragrances in cosmetic products, and aromas or probiotics in food.
However, todays industrial microencapsulation techniques do not allow any control over the capsule size, leading to uncontrolled release profiles.
Our unique technique enables the industrial production of size-controlled
microcapsules, while offering precise dosing, controlled release properties, and an increased stability, all of which being 1000x faster than state-of-the-art processes.
Microcaps brings, for the very first time, industrial precision and control to the rapidly growing 12 bn-$ market of microencapsulation.
Innosuisse funds 33 projects as part of the Swiss Accelerator (startupticker.ch)
Microcaps raises CHF 9.3 million to expand production capacity (startupticker.ch)
Microcaps Secures CHF 9.3 million in Series A Funding to expand production of ethanol-free Perfume Pearls (venturelab.swiss)
Startup-Technologie für High End-Produkte (startupticker.ch)
The 9 most promising engineering startups of 2022, according to investors (TOP 100)
TOP 100 Satellite Event: 5 TOP 100 Swiss Startups pitch to Credit Suisse investors (TOP 100)
Microcaps wins a Swiss luxury brand as the first customer (startupticker.ch)
Sechs Startups unter den Finalisten des Swiss Technology Award (startupticker.ch)
Startups saving lives and saving money supported by Venture Kick (startupticker.ch)
This is Microcaps
Pitch Night at Swissnex San Francisco